Chimaobi Nwevo

Reversible Ventricular Dysfunction in Tachycardia-induced Cardiomyopathy: Implications for Timing of ICD Therapy

Bethel O. Anekwe, Adaku S. Ndubisi & Chimaobi Nwevo · Asian Journal of Research in Cardiovascular Diseases · 2026

Tachycardia-induced cardiomyopathy is a potentially reversible cause of left ventricular systolic dysfunction that can develop in the setting of persistent or frequently recurrent tachyarrhythmias. Recognition is clinically important because ventricular recovery after rhythm cont...

Open access Research Article 10.9734/ajrcd/2026/v8i1170

Innovations in Drug-Coated Balloons and Stentless Coronary Interventions: Evaluating the Evidence, Limitations, and Future Prospects in De-Novo Lesion Management

George Davidson, Nwachukwu O. Nwachukwu, Chimaobi Nwevo, Ahmed Ismail Ali, Nwamaka C. Bob-Ume, Abduljabbar A. Abdulaziz, Adu Agyen Kwame, Muhiyadin S. Ali, Alexander C. Ogbodo & Obinna D. Nwaizuzu · Cardiology and Angiology: An International Journal · 2026

Coronary artery disease (CAD) remains a major cause of morbidity and mortality, and percutaneous coronary intervention (PCI) is central to the management of obstructive coronary disease. Although drug-eluting stents (DESs) have reduced restenosis and repeat revascularisation, the...

Open access Research Article 10.9734/ca/2026/v15i3553